FATE THERAPEUTICS INC (FATE) Net margin 2016–2025
FATE THERAPEUTICS INC (FATE) net profit margin by fiscal year — reported net income divided by reported revenue.
-2051.1%FY2025 · since FY2016: -760.2% → -2051.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -2051.1% | -684.6 pp |
| FY2024 | -1366.5% | -1113.2 pp |
| FY2023 | -253.3% | +39.2 pp |
| FY2022 | -292.5% | +87.3 pp |
| FY2021 | -379.9% | +171.7 pp |
| FY2020 | -551.6% | +367.4 pp |
| FY2019 | -919.0% | +486.0 pp |
| FY2018 | -1405.0% | -358.9 pp |
| FY2017 | -1046.1% | -285.9 pp |
| FY2016 | -760.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More FATE financial trends
FATE RevenueFATE Net incomeFATE Gross profitFATE Gross marginFATE Operating incomeFATE Operating marginFATE Operating cash flowFATE Free cash flowFATE Capital expendituresFATE Return on equityFATE Stock buybacksFATE Dividends paidFATE Total assetsFATE Total liabilitiesFATE Shareholders’ equityFATE overview →